Literature DB >> 32974956

Case of pemphigoid with immunoglobulin G antibodies to BP180 C-terminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination.

Nobuki Maki1, Takashi Hashimoto2, Tomoko Yamada3, Norito Ishii4, Daisuke Tsuruta2, Toshio Demitsu5.   

Abstract

Pemphigoid cases have been reported in association with vaccination, including pneumococcal vaccination in infants but not in adults. There are also sporadic reports of pemphigoid diseases involving reactions to multiple autoantigens. We herein report a 75-year-old Japanese patient with pemphigoid who had immunoglobulin G antibodies to both the BP180 C-terminal domain and laminin-γ1 (p200), which developed 1 day after pneumococcal vaccination.
© 2020 Japanese Dermatological Association.

Entities:  

Keywords:  BP180; laminin-γ1 (p200); pemphigoid disease; pneumococcal vaccination; trigger

Mesh：

Substances：

Year:  2020        PMID： 32974956     DOI： 10.1111/1346-8138.15626

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


  5 in total

1.  A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine.

Authors:  J Young; L Mercieca; M Ceci; D Pisani; A Betts; M J Boffa
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-05       Impact factor: 9.228

2.  Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.

Authors:  Massimo Dell'Antonia; Speranza Anedda; Federica Usai; Laura Atzori; Caterina Ferreli
Journal:  Dermatol Ther       Date:  2021-11-30       Impact factor: 3.858

3.  Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.

Authors:  Carlo Alberto Maronese; Marzia Caproni; Chiara Moltrasio; Giovanni Genovese; Pamela Vezzoli; Paolo Sena; Giulia Previtali; Emanuele Cozzani; Giulia Gasparini; Aurora Parodi; Laura Atzori; Emiliano Antiga; Roberto Maglie; Francesco Moro; Elena Biancamaria Mariotti; Alberto Corrà; Sabatino Pallotta; Biagio Didona; Angelo Valerio Marzano; Giovanni Di Zenzo
Journal:  Front Med (Lausanne)       Date:  2022-02-28

4.  Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.

Authors:  Ying-Han Xie; Si-Hang Wang; Si-Zhe Li; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

5.  Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et al.

Authors:  Fabrizio Martora; Angelo Ruggiero; Teresa Battista; Gabriella Fabbrocini; Matteo Megna
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-16       Impact factor: 9.228
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.